nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—KCNH2—Loratadine—allergic rhinitis	0.0693	0.117	CbGbCtD
Carvedilol—PTGS1—Montelukast—allergic rhinitis	0.0443	0.0751	CbGbCtD
Carvedilol—PTGS1—Diphenhydramine—allergic rhinitis	0.0443	0.0751	CbGbCtD
Carvedilol—CYP1A2—Desloratadine—allergic rhinitis	0.0344	0.0584	CbGbCtD
Carvedilol—CYP2C9—Desloratadine—allergic rhinitis	0.031	0.0526	CbGbCtD
Carvedilol—ABCB1—Desloratadine—allergic rhinitis	0.0301	0.0511	CbGbCtD
Carvedilol—CYP2D6—Desloratadine—allergic rhinitis	0.0284	0.0481	CbGbCtD
Carvedilol—CYP1A2—Diphenhydramine—allergic rhinitis	0.0198	0.0335	CbGbCtD
Carvedilol—CYP3A4—Flunisolide—allergic rhinitis	0.018	0.0306	CbGbCtD
Carvedilol—CYP2C9—Montelukast—allergic rhinitis	0.0178	0.0302	CbGbCtD
Carvedilol—CYP2C9—Loratadine—allergic rhinitis	0.0178	0.0302	CbGbCtD
Carvedilol—CYP2C9—Diphenhydramine—allergic rhinitis	0.0178	0.0302	CbGbCtD
Carvedilol—ABCB1—Loratadine—allergic rhinitis	0.0173	0.0293	CbGbCtD
Carvedilol—CYP3A4—Olopatadine—allergic rhinitis	0.017	0.0288	CbGbCtD
Carvedilol—CYP2D6—Loratadine—allergic rhinitis	0.0163	0.0276	CbGbCtD
Carvedilol—CYP2D6—Diphenhydramine—allergic rhinitis	0.0163	0.0276	CbGbCtD
Carvedilol—ABCB1—Methylprednisolone—allergic rhinitis	0.0158	0.0268	CbGbCtD
Carvedilol—CYP1A1—Dexamethasone—allergic rhinitis	0.0153	0.026	CbGbCtD
Carvedilol—CYP2E1—Dexamethasone—allergic rhinitis	0.0118	0.0201	CbGbCtD
Carvedilol—CYP3A4—Montelukast—allergic rhinitis	0.0104	0.0176	CbGbCtD
Carvedilol—CYP3A4—Loratadine—allergic rhinitis	0.0104	0.0176	CbGbCtD
Carvedilol—ABCB1—Betamethasone—allergic rhinitis	0.0103	0.0174	CbGbCtD
Carvedilol—ABCB1—Prednisolone—allergic rhinitis	0.0102	0.0172	CbGbCtD
Carvedilol—ABCB1—Hydrocortisone—allergic rhinitis	0.00962	0.0163	CbGbCtD
Carvedilol—CYP3A4—Methylprednisolone—allergic rhinitis	0.00948	0.0161	CbGbCtD
Carvedilol—CYP3A4—Triamcinolone—allergic rhinitis	0.00718	0.0122	CbGbCtD
Carvedilol—CYP2C9—Dexamethasone—allergic rhinitis	0.00617	0.0105	CbGbCtD
Carvedilol—CYP3A4—Betamethasone—allergic rhinitis	0.00616	0.0104	CbGbCtD
Carvedilol—CYP3A4—Prednisolone—allergic rhinitis	0.00608	0.0103	CbGbCtD
Carvedilol—ABCB1—Dexamethasone—allergic rhinitis	0.00598	0.0101	CbGbCtD
Carvedilol—CYP3A4—Hydrocortisone—allergic rhinitis	0.00577	0.00977	CbGbCtD
Carvedilol—CYP2D6—Dexamethasone—allergic rhinitis	0.00564	0.00956	CbGbCtD
Carvedilol—NDUFC2—exocrine gland—allergic rhinitis	0.0043	0.0478	CbGeAlD
Carvedilol—CYP3A4—Dexamethasone—allergic rhinitis	0.00359	0.00608	CbGbCtD
Carvedilol—SELE—respiratory system—allergic rhinitis	0.003	0.0333	CbGeAlD
Carvedilol—VCAM1—respiratory system—allergic rhinitis	0.00276	0.0306	CbGeAlD
Carvedilol—HIF1A—respiratory system—allergic rhinitis	0.00265	0.0295	CbGeAlD
Carvedilol—GJA1—respiratory system—allergic rhinitis	0.00257	0.0286	CbGeAlD
Carvedilol—VCAM1—eye—allergic rhinitis	0.00252	0.028	CbGeAlD
Carvedilol—SELE—epithelium—allergic rhinitis	0.0025	0.0278	CbGeAlD
Carvedilol—SELE—bronchus—allergic rhinitis	0.00247	0.0274	CbGeAlD
Carvedilol—HIF1A—eye—allergic rhinitis	0.00242	0.0269	CbGeAlD
Carvedilol—SELE—skin of body—allergic rhinitis	0.00238	0.0265	CbGeAlD
Carvedilol—GJA1—eye—allergic rhinitis	0.00235	0.0261	CbGeAlD
Carvedilol—VCAM1—epithelium—allergic rhinitis	0.0023	0.0256	CbGeAlD
Carvedilol—VCAM1—bronchus—allergic rhinitis	0.00227	0.0252	CbGeAlD
Carvedilol—NDUFC2—respiratory system—allergic rhinitis	0.00224	0.0249	CbGeAlD
Carvedilol—HIF1A—epithelium—allergic rhinitis	0.00222	0.0246	CbGeAlD
Carvedilol—SELE—trachea—allergic rhinitis	0.00221	0.0246	CbGeAlD
Carvedilol—HIF1A—bronchus—allergic rhinitis	0.00218	0.0242	CbGeAlD
Carvedilol—GJA1—epithelium—allergic rhinitis	0.00215	0.0239	CbGeAlD
Carvedilol—GJA1—bronchus—allergic rhinitis	0.00212	0.0235	CbGeAlD
Carvedilol—HIF1A—skin of body—allergic rhinitis	0.00211	0.0234	CbGeAlD
Carvedilol—NDUFC2—eye—allergic rhinitis	0.00205	0.0227	CbGeAlD
Carvedilol—GJA1—skin of body—allergic rhinitis	0.00204	0.0227	CbGeAlD
Carvedilol—VCAM1—trachea—allergic rhinitis	0.00204	0.0226	CbGeAlD
Carvedilol—HIF1A—trachea—allergic rhinitis	0.00196	0.0218	CbGeAlD
Carvedilol—GJA1—trachea—allergic rhinitis	0.0019	0.0211	CbGeAlD
Carvedilol—NDUFC2—epithelium—allergic rhinitis	0.00187	0.0208	CbGeAlD
Carvedilol—NDUFC2—bronchus—allergic rhinitis	0.00184	0.0205	CbGeAlD
Carvedilol—VEGFA—bronchus—allergic rhinitis	0.00167	0.0186	CbGeAlD
Carvedilol—NDUFC2—trachea—allergic rhinitis	0.00165	0.0184	CbGeAlD
Carvedilol—SELE—lung—allergic rhinitis	0.00159	0.0177	CbGeAlD
Carvedilol—VEGFA—trachea—allergic rhinitis	0.0015	0.0167	CbGeAlD
Carvedilol—VCAM1—lung—allergic rhinitis	0.00146	0.0163	CbGeAlD
Carvedilol—HIF1A—lung—allergic rhinitis	0.00141	0.0156	CbGeAlD
Carvedilol—GJA1—lung—allergic rhinitis	0.00137	0.0152	CbGeAlD
Carvedilol—NDUFC2—lung—allergic rhinitis	0.00119	0.0132	CbGeAlD
Carvedilol—ADRA1D—epithelium—allergic rhinitis	0.00111	0.0123	CbGeAlD
Carvedilol—VEGFA—lung—allergic rhinitis	0.00108	0.012	CbGeAlD
Carvedilol—ADRB1—bronchus—allergic rhinitis	0.000793	0.00881	CbGeAlD
Carvedilol—ADRA1A—epithelium—allergic rhinitis	0.000637	0.00707	CbGeAlD
Carvedilol—CYP1A2—respiratory system—allergic rhinitis	0.00063	0.007	CbGeAlD
Carvedilol—CYP1A1—respiratory system—allergic rhinitis	0.000622	0.0069	CbGeAlD
Carvedilol—ADRA2C—bronchus—allergic rhinitis	0.000598	0.00664	CbGeAlD
Carvedilol—CYP2E1—respiratory system—allergic rhinitis	0.000567	0.0063	CbGeAlD
Carvedilol—GJA1—Rimexolone—Flunisolide—allergic rhinitis	0.000561	0.0925	CbGdCrCtD
Carvedilol—PTGS1—respiratory system—allergic rhinitis	0.000546	0.00607	CbGeAlD
Carvedilol—ADRA2C—trachea—allergic rhinitis	0.000537	0.00596	CbGeAlD
Carvedilol—CYP1A1—epithelium—allergic rhinitis	0.00052	0.00577	CbGeAlD
Carvedilol—ADRB1—lung—allergic rhinitis	0.000512	0.00568	CbGeAlD
Carvedilol—CYP1A1—bronchus—allergic rhinitis	0.000512	0.00568	CbGeAlD
Carvedilol—CYP1A1—skin of body—allergic rhinitis	0.000494	0.00549	CbGeAlD
Carvedilol—ADRA2A—bronchus—allergic rhinitis	0.000477	0.0053	CbGeAlD
Carvedilol—CYP1A1—trachea—allergic rhinitis	0.000459	0.0051	CbGeAlD
Carvedilol—PTGS1—epithelium—allergic rhinitis	0.000456	0.00507	CbGeAlD
Carvedilol—GJA1—Phenytoin—Diphenhydramine—allergic rhinitis	0.000456	0.0751	CbGdCrCtD
Carvedilol—PTGS1—skin of body—allergic rhinitis	0.000434	0.00482	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Hydrocortisone—allergic rhinitis	0.000433	0.0713	CbGdCrCtD
Carvedilol—ADRA2A—trachea—allergic rhinitis	0.000428	0.00476	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Methylprednisolone—allergic rhinitis	0.000408	0.0673	CbGdCrCtD
Carvedilol—PTGS1—trachea—allergic rhinitis	0.000404	0.00448	CbGeAlD
Carvedilol—ADRA2C—lung—allergic rhinitis	0.000386	0.00428	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Prednisolone—allergic rhinitis	0.000364	0.0599	CbGdCrCtD
Carvedilol—CYP1A2—lung—allergic rhinitis	0.000335	0.00372	CbGeAlD
Carvedilol—CYP1A1—lung—allergic rhinitis	0.00033	0.00367	CbGeAlD
Carvedilol—ABCB1—respiratory system—allergic rhinitis	0.000323	0.00359	CbGeAlD
Carvedilol—ADRA2A—lung—allergic rhinitis	0.000308	0.00342	CbGeAlD
Carvedilol—CYP2E1—lung—allergic rhinitis	0.000301	0.00334	CbGeAlD
Carvedilol—GJA1—Rimexolone—Hydrocortisone—allergic rhinitis	0.000291	0.048	CbGdCrCtD
Carvedilol—PTGS1—lung—allergic rhinitis	0.00029	0.00322	CbGeAlD
Carvedilol—GJA1—Rimexolone—Methylprednisolone—allergic rhinitis	0.000275	0.0453	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Dexamethasone—allergic rhinitis	0.00027	0.0446	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Betamethasone—allergic rhinitis	0.00027	0.0446	CbGdCrCtD
Carvedilol—ABCB1—epithelium—allergic rhinitis	0.00027	0.003	CbGeAlD
Carvedilol—GJA1—Rimexolone—Triamcinolone—allergic rhinitis	0.000264	0.0435	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Prednisolone—allergic rhinitis	0.000245	0.0403	CbGdCrCtD
Carvedilol—ABCB1—trachea—allergic rhinitis	0.000239	0.00265	CbGeAlD
Carvedilol—VEGFA—Carbinoxamine—Diphenhydramine—allergic rhinitis	0.000216	0.0356	CbGdCrCtD
Carvedilol—GJA1—Progesterone—Hydrocortisone—allergic rhinitis	0.000212	0.0349	CbGdCrCtD
Carvedilol—GJA1—Progesterone—Prednisolone—allergic rhinitis	0.000178	0.0293	CbGdCrCtD
Carvedilol—ABCB1—lung—allergic rhinitis	0.000171	0.0019	CbGeAlD
Carvedilol—GJA1—Dexamethasone—Flunisolide—allergic rhinitis	0.000127	0.0209	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Flunisolide—allergic rhinitis	0.000127	0.0209	CbGdCrCtD
Carvedilol—Dizziness—Montelukast—allergic rhinitis	0.000127	0.000561	CcSEcCtD
Carvedilol—Bradycardia—Dexamethasone—allergic rhinitis	0.000127	0.00056	CcSEcCtD
Carvedilol—Bradycardia—Betamethasone—allergic rhinitis	0.000127	0.00056	CcSEcCtD
Carvedilol—Haemoglobin—Betamethasone—allergic rhinitis	0.000125	0.000553	CcSEcCtD
Carvedilol—Haemoglobin—Dexamethasone—allergic rhinitis	0.000125	0.000553	CcSEcCtD
Carvedilol—Haemorrhage—Dexamethasone—allergic rhinitis	0.000125	0.000551	CcSEcCtD
Carvedilol—Haemorrhage—Betamethasone—allergic rhinitis	0.000125	0.000551	CcSEcCtD
Carvedilol—Angiopathy—Methylprednisolone—allergic rhinitis	0.000124	0.000549	CcSEcCtD
Carvedilol—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000124	0.000547	CcSEcCtD
Carvedilol—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000124	0.000546	CcSEcCtD
Carvedilol—Vision blurred—Prednisolone—allergic rhinitis	0.000123	0.000541	CcSEcCtD
Carvedilol—Vomiting—Montelukast—allergic rhinitis	0.000122	0.000539	CcSEcCtD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000122	0.00139	CbGpPWpGaD
Carvedilol—Rash—Montelukast—allergic rhinitis	0.000121	0.000535	CcSEcCtD
Carvedilol—Dermatitis—Montelukast—allergic rhinitis	0.000121	0.000534	CcSEcCtD
Carvedilol—Ill-defined disorder—Prednisolone—allergic rhinitis	0.000121	0.000533	CcSEcCtD
Carvedilol—Headache—Montelukast—allergic rhinitis	0.00012	0.000531	CcSEcCtD
Carvedilol—Visual impairment—Dexamethasone—allergic rhinitis	0.00012	0.000531	CcSEcCtD
Carvedilol—Visual impairment—Betamethasone—allergic rhinitis	0.00012	0.000531	CcSEcCtD
Carvedilol—Malnutrition—Methylprednisolone—allergic rhinitis	0.000119	0.000527	CcSEcCtD
Carvedilol—Angioedema—Prednisolone—allergic rhinitis	0.000119	0.000525	CcSEcCtD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000119	0.00136	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CCL11—allergic rhinitis	0.000119	0.00136	CbGpPWpGaD
Carvedilol—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000118	0.00052	CcSEcCtD
Carvedilol—Malaise—Prednisolone—allergic rhinitis	0.000117	0.000518	CcSEcCtD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000117	0.00134	CbGpPWpGaD
Carvedilol—Vertigo—Prednisolone—allergic rhinitis	0.000117	0.000516	CcSEcCtD
Carvedilol—Syncope—Prednisolone—allergic rhinitis	0.000117	0.000515	CcSEcCtD
Carvedilol—VCAM1—Immune System—HLA-DQB1—allergic rhinitis	0.000117	0.00133	CbGpPWpGaD
Carvedilol—Angioedema—Hydrocortisone—allergic rhinitis	0.000116	0.000513	CcSEcCtD
Carvedilol—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000116	0.00133	CbGpPWpGaD
Carvedilol—Back pain—Triamcinolone—allergic rhinitis	0.000116	0.000511	CcSEcCtD
Carvedilol—ADRA1A—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000115	0.00132	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000115	0.00131	CbGpPWpGaD
Carvedilol—Malaise—Hydrocortisone—allergic rhinitis	0.000115	0.000506	CcSEcCtD
Carvedilol—Loss of consciousness—Prednisolone—allergic rhinitis	0.000114	0.000505	CcSEcCtD
Carvedilol—Vertigo—Hydrocortisone—allergic rhinitis	0.000114	0.000504	CcSEcCtD
Carvedilol—Nausea—Montelukast—allergic rhinitis	0.000114	0.000504	CcSEcCtD
Carvedilol—Syncope—Hydrocortisone—allergic rhinitis	0.000114	0.000503	CcSEcCtD
Carvedilol—Angiopathy—Dexamethasone—allergic rhinitis	0.000113	0.0005	CcSEcCtD
Carvedilol—Angiopathy—Betamethasone—allergic rhinitis	0.000113	0.0005	CcSEcCtD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000113	0.0013	CbGpPWpGaD
Carvedilol—Convulsion—Prednisolone—allergic rhinitis	0.000113	0.000498	CcSEcCtD
Carvedilol—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000113	0.00129	CbGpPWpGaD
Carvedilol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000113	0.00129	CbGpPWpGaD
Carvedilol—Hypertension—Prednisolone—allergic rhinitis	0.000112	0.000496	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Flunisolide—allergic rhinitis	0.000112	0.0185	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Flunisolide—allergic rhinitis	0.000112	0.0185	CbGdCrCtD
Carvedilol—ADRB1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000112	0.00128	CbGpPWpGaD
Carvedilol—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000112	0.000493	CcSEcCtD
Carvedilol—ADRA1B—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000111	0.00127	CbGpPWpGaD
Carvedilol—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.000111	0.00049	CcSEcCtD
Carvedilol—ADRA2B—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000111	0.00127	CbGpPWpGaD
Carvedilol—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.000111	0.000489	CcSEcCtD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00011	0.00126	CbGpPWpGaD
Carvedilol—Alopecia—Dexamethasone—allergic rhinitis	0.00011	0.000487	CcSEcCtD
Carvedilol—Alopecia—Betamethasone—allergic rhinitis	0.00011	0.000487	CcSEcCtD
Carvedilol—Convulsion—Hydrocortisone—allergic rhinitis	0.00011	0.000486	CcSEcCtD
Carvedilol—Hypertension—Hydrocortisone—allergic rhinitis	0.00011	0.000484	CcSEcCtD
Carvedilol—VEGFA—Hemostasis—IL5—allergic rhinitis	0.00011	0.00126	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL10—allergic rhinitis	0.00011	0.00125	CbGpPWpGaD
Carvedilol—Discomfort—Prednisolone—allergic rhinitis	0.000109	0.000483	CcSEcCtD
Carvedilol—ADRB2—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000109	0.00125	CbGpPWpGaD
Carvedilol—Angioedema—Triamcinolone—allergic rhinitis	0.000109	0.000483	CcSEcCtD
Carvedilol—Angioedema—Methylprednisolone—allergic rhinitis	0.000109	0.000482	CcSEcCtD
Carvedilol—VEGFA—Developmental Biology—ADIPOQ—allergic rhinitis	0.000108	0.00124	CbGpPWpGaD
Carvedilol—Myalgia—Hydrocortisone—allergic rhinitis	0.000108	0.000478	CcSEcCtD
Carvedilol—ADRB1—GPCR ligand binding—CCL11—allergic rhinitis	0.000108	0.00124	CbGpPWpGaD
Carvedilol—Malaise—Triamcinolone—allergic rhinitis	0.000108	0.000476	CcSEcCtD
Carvedilol—Malaise—Methylprednisolone—allergic rhinitis	0.000108	0.000475	CcSEcCtD
Carvedilol—Vertigo—Triamcinolone—allergic rhinitis	0.000108	0.000475	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000107	0.000474	CcSEcCtD
Carvedilol—Syncope—Triamcinolone—allergic rhinitis	0.000107	0.000474	CcSEcCtD
Carvedilol—Vertigo—Methylprednisolone—allergic rhinitis	0.000107	0.000474	CcSEcCtD
Carvedilol—ADRA2A—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000107	0.00123	CbGpPWpGaD
Carvedilol—Syncope—Methylprednisolone—allergic rhinitis	0.000107	0.000473	CcSEcCtD
Carvedilol—ADRA2B—GPCR ligand binding—CCL11—allergic rhinitis	0.000107	0.00123	CbGpPWpGaD
Carvedilol—Discomfort—Hydrocortisone—allergic rhinitis	0.000107	0.000472	CcSEcCtD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000107	0.00122	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL4—allergic rhinitis	0.000107	0.00122	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000107	0.00122	CbGpPWpGaD
Carvedilol—Oedema—Prednisolone—allergic rhinitis	0.000106	0.000469	CcSEcCtD
Carvedilol—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000106	0.000469	CcSEcCtD
Carvedilol—ADRB2—GPCR ligand binding—CCL11—allergic rhinitis	0.000106	0.00121	CbGpPWpGaD
Carvedilol—Loss of consciousness—Triamcinolone—allergic rhinitis	0.000105	0.000464	CcSEcCtD
Carvedilol—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.000105	0.000463	CcSEcCtD
Carvedilol—Shock—Prednisolone—allergic rhinitis	0.000105	0.000461	CcSEcCtD
Carvedilol—Cough—Triamcinolone—allergic rhinitis	0.000104	0.000461	CcSEcCtD
Carvedilol—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.000104	0.000458	CcSEcCtD
Carvedilol—Oedema—Hydrocortisone—allergic rhinitis	0.000104	0.000458	CcSEcCtD
Carvedilol—Convulsion—Triamcinolone—allergic rhinitis	0.000104	0.000458	CcSEcCtD
Carvedilol—Tachycardia—Prednisolone—allergic rhinitis	0.000104	0.000458	CcSEcCtD
Carvedilol—ADRA2C—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000104	0.00119	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000104	0.00118	CbGpPWpGaD
Carvedilol—Convulsion—Methylprednisolone—allergic rhinitis	0.000103	0.000457	CcSEcCtD
Carvedilol—Hypertension—Triamcinolone—allergic rhinitis	0.000103	0.000456	CcSEcCtD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.000103	0.00118	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000103	0.00118	CbGpPWpGaD
Carvedilol—Hypertension—Methylprednisolone—allergic rhinitis	0.000103	0.000455	CcSEcCtD
Carvedilol—Infection—Hydrocortisone—allergic rhinitis	0.000103	0.000455	CcSEcCtD
Carvedilol—VCAM1—Adaptive Immune System—CD4—allergic rhinitis	0.000103	0.00118	CbGpPWpGaD
Carvedilol—Hyperhidrosis—Prednisolone—allergic rhinitis	0.000103	0.000453	CcSEcCtD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000102	0.00117	CbGpPWpGaD
Carvedilol—Shock—Hydrocortisone—allergic rhinitis	0.000102	0.00045	CcSEcCtD
Carvedilol—ADRA1B—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000102	0.00117	CbGpPWpGaD
Carvedilol—Myalgia—Triamcinolone—allergic rhinitis	0.000102	0.00045	CcSEcCtD
Carvedilol—Arthralgia—Methylprednisolone—allergic rhinitis	0.000102	0.000449	CcSEcCtD
Carvedilol—Myalgia—Methylprednisolone—allergic rhinitis	0.000102	0.000449	CcSEcCtD
Carvedilol—Tachycardia—Hydrocortisone—allergic rhinitis	0.000101	0.000447	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000101	0.000446	CcSEcCtD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000101	0.00115	CbGpPWpGaD
Carvedilol—Skin disorder—Hydrocortisone—allergic rhinitis	0.000101	0.000445	CcSEcCtD
Carvedilol—Ill-defined disorder—Dexamethasone—allergic rhinitis	0.000101	0.000445	CcSEcCtD
Carvedilol—Ill-defined disorder—Betamethasone—allergic rhinitis	0.000101	0.000445	CcSEcCtD
Carvedilol—Discomfort—Triamcinolone—allergic rhinitis	0.000101	0.000444	CcSEcCtD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.000101	0.00115	CbGpPWpGaD
Carvedilol—Discomfort—Methylprednisolone—allergic rhinitis	0.0001	0.000443	CcSEcCtD
Carvedilol—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.0001	0.000443	CcSEcCtD
Carvedilol—ADRA2C—GPCR ligand binding—CCL11—allergic rhinitis	0.0001	0.00114	CbGpPWpGaD
Carvedilol—Dry mouth—Triamcinolone—allergic rhinitis	9.97e-05	0.00044	CcSEcCtD
Carvedilol—Angioedema—Dexamethasone—allergic rhinitis	9.93e-05	0.000438	CcSEcCtD
Carvedilol—Angioedema—Betamethasone—allergic rhinitis	9.93e-05	0.000438	CcSEcCtD
Carvedilol—Anorexia—Hydrocortisone—allergic rhinitis	9.89e-05	0.000436	CcSEcCtD
Carvedilol—ADRA1B—GPCR ligand binding—CCL11—allergic rhinitis	9.85e-05	0.00113	CbGpPWpGaD
Carvedilol—Confusional state—Methylprednisolone—allergic rhinitis	9.83e-05	0.000434	CcSEcCtD
Carvedilol—Malaise—Betamethasone—allergic rhinitis	9.8e-05	0.000432	CcSEcCtD
Carvedilol—Malaise—Dexamethasone—allergic rhinitis	9.8e-05	0.000432	CcSEcCtD
Carvedilol—Oedema—Triamcinolone—allergic rhinitis	9.77e-05	0.000431	CcSEcCtD
Carvedilol—Anaphylactic shock—Triamcinolone—allergic rhinitis	9.77e-05	0.000431	CcSEcCtD
Carvedilol—Vertigo—Dexamethasone—allergic rhinitis	9.76e-05	0.000431	CcSEcCtD
Carvedilol—Vertigo—Betamethasone—allergic rhinitis	9.76e-05	0.000431	CcSEcCtD
Carvedilol—Anaphylactic shock—Methylprednisolone—allergic rhinitis	9.75e-05	0.00043	CcSEcCtD
Carvedilol—Syncope—Dexamethasone—allergic rhinitis	9.74e-05	0.00043	CcSEcCtD
Carvedilol—Syncope—Betamethasone—allergic rhinitis	9.74e-05	0.00043	CcSEcCtD
Carvedilol—Infection—Triamcinolone—allergic rhinitis	9.71e-05	0.000428	CcSEcCtD
Carvedilol—Hypotension—Hydrocortisone—allergic rhinitis	9.7e-05	0.000428	CcSEcCtD
Carvedilol—Infection—Methylprednisolone—allergic rhinitis	9.68e-05	0.000427	CcSEcCtD
Carvedilol—ADRB3—Signaling by GPCR—CYSLTR1—allergic rhinitis	9.68e-05	0.00111	CbGpPWpGaD
Carvedilol—Shock—Triamcinolone—allergic rhinitis	9.61e-05	0.000424	CcSEcCtD
Carvedilol—Insomnia—Prednisolone—allergic rhinitis	9.61e-05	0.000424	CcSEcCtD
Carvedilol—Shock—Methylprednisolone—allergic rhinitis	9.59e-05	0.000423	CcSEcCtD
Carvedilol—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	9.55e-05	0.00109	CbGpPWpGaD
Carvedilol—Loss of consciousness—Dexamethasone—allergic rhinitis	9.55e-05	0.000421	CcSEcCtD
Carvedilol—Loss of consciousness—Betamethasone—allergic rhinitis	9.55e-05	0.000421	CcSEcCtD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	9.55e-05	0.00109	CbGpPWpGaD
Carvedilol—Paraesthesia—Prednisolone—allergic rhinitis	9.54e-05	0.000421	CcSEcCtD
Carvedilol—Tachycardia—Triamcinolone—allergic rhinitis	9.54e-05	0.000421	CcSEcCtD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	9.52e-05	0.00109	CbGpPWpGaD
Carvedilol—Tachycardia—Methylprednisolone—allergic rhinitis	9.51e-05	0.00042	CcSEcCtD
Carvedilol—Skin disorder—Methylprednisolone—allergic rhinitis	9.47e-05	0.000418	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	9.45e-05	0.000417	CcSEcCtD
Carvedilol—Hyperhidrosis—Triamcinolone—allergic rhinitis	9.44e-05	0.000417	CcSEcCtD
Carvedilol—Hyperhidrosis—Methylprednisolone—allergic rhinitis	9.42e-05	0.000416	CcSEcCtD
Carvedilol—Convulsion—Dexamethasone—allergic rhinitis	9.41e-05	0.000415	CcSEcCtD
Carvedilol—Convulsion—Betamethasone—allergic rhinitis	9.41e-05	0.000415	CcSEcCtD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	9.39e-05	0.00107	CbGpPWpGaD
Carvedilol—Insomnia—Hydrocortisone—allergic rhinitis	9.38e-05	0.000414	CcSEcCtD
Carvedilol—Hypertension—Betamethasone—allergic rhinitis	9.38e-05	0.000414	CcSEcCtD
Carvedilol—Hypertension—Dexamethasone—allergic rhinitis	9.38e-05	0.000414	CcSEcCtD
Carvedilol—ADRB3—Signaling by GPCR—CCL11—allergic rhinitis	9.35e-05	0.00107	CbGpPWpGaD
Carvedilol—Paraesthesia—Hydrocortisone—allergic rhinitis	9.32e-05	0.000411	CcSEcCtD
Carvedilol—HIF1A—Signaling Pathways—TAC1—allergic rhinitis	9.28e-05	0.00106	CbGpPWpGaD
Carvedilol—Myalgia—Betamethasone—allergic rhinitis	9.25e-05	0.000408	CcSEcCtD
Carvedilol—Myalgia—Dexamethasone—allergic rhinitis	9.25e-05	0.000408	CcSEcCtD
Carvedilol—Discomfort—Dexamethasone—allergic rhinitis	9.14e-05	0.000403	CcSEcCtD
Carvedilol—Discomfort—Betamethasone—allergic rhinitis	9.14e-05	0.000403	CcSEcCtD
Carvedilol—Dyspepsia—Hydrocortisone—allergic rhinitis	9.13e-05	0.000403	CcSEcCtD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	9.13e-05	0.00104	CbGpPWpGaD
Carvedilol—Hypotension—Methylprednisolone—allergic rhinitis	9.11e-05	0.000402	CcSEcCtD
Carvedilol—Pain—Prednisolone—allergic rhinitis	9.09e-05	0.000401	CcSEcCtD
Carvedilol—ADRA1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.06e-05	0.00104	CbGpPWpGaD
Carvedilol—Decreased appetite—Hydrocortisone—allergic rhinitis	9.02e-05	0.000398	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	8.96e-05	0.000395	CcSEcCtD
Carvedilol—Fatigue—Hydrocortisone—allergic rhinitis	8.95e-05	0.000395	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	8.9e-05	0.000393	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	8.88e-05	0.000392	CcSEcCtD
Carvedilol—VCAM1—Adaptive Immune System—NFKB1—allergic rhinitis	8.88e-05	0.00102	CbGpPWpGaD
Carvedilol—Pain—Hydrocortisone—allergic rhinitis	8.87e-05	0.000392	CcSEcCtD
Carvedilol—Oedema—Betamethasone—allergic rhinitis	8.86e-05	0.000391	CcSEcCtD
Carvedilol—Anaphylactic shock—Dexamethasone—allergic rhinitis	8.86e-05	0.000391	CcSEcCtD
Carvedilol—Oedema—Dexamethasone—allergic rhinitis	8.86e-05	0.000391	CcSEcCtD
Carvedilol—Anaphylactic shock—Betamethasone—allergic rhinitis	8.86e-05	0.000391	CcSEcCtD
Carvedilol—ADRA1D—GPCR downstream signaling—PTGDR2—allergic rhinitis	8.85e-05	0.00101	CbGpPWpGaD
Carvedilol—Insomnia—Triamcinolone—allergic rhinitis	8.84e-05	0.00039	CcSEcCtD
Carvedilol—Insomnia—Methylprednisolone—allergic rhinitis	8.82e-05	0.000389	CcSEcCtD
Carvedilol—Infection—Betamethasone—allergic rhinitis	8.81e-05	0.000389	CcSEcCtD
Carvedilol—Infection—Dexamethasone—allergic rhinitis	8.81e-05	0.000389	CcSEcCtD
Carvedilol—Paraesthesia—Triamcinolone—allergic rhinitis	8.77e-05	0.000387	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisolone—allergic rhinitis	8.75e-05	0.000386	CcSEcCtD
Carvedilol—Paraesthesia—Methylprednisolone—allergic rhinitis	8.75e-05	0.000386	CcSEcCtD
Carvedilol—ADRA1A—GPCR ligand binding—CCL11—allergic rhinitis	8.75e-05	0.001	CbGpPWpGaD
Carvedilol—PTGS1—Selenium Micronutrient Network—NFKB1—allergic rhinitis	8.74e-05	0.001	CbGpPWpGaD
Carvedilol—Shock—Dexamethasone—allergic rhinitis	8.72e-05	0.000385	CcSEcCtD
Carvedilol—Shock—Betamethasone—allergic rhinitis	8.72e-05	0.000385	CcSEcCtD
Carvedilol—Dyspnoea—Triamcinolone—allergic rhinitis	8.71e-05	0.000384	CcSEcCtD
Carvedilol—Thrombocytopenia—Betamethasone—allergic rhinitis	8.68e-05	0.000383	CcSEcCtD
Carvedilol—Thrombocytopenia—Dexamethasone—allergic rhinitis	8.68e-05	0.000383	CcSEcCtD
Carvedilol—HIF1A—Disease—SMAD3—allergic rhinitis	8.67e-05	0.000992	CbGpPWpGaD
Carvedilol—Tachycardia—Betamethasone—allergic rhinitis	8.65e-05	0.000382	CcSEcCtD
Carvedilol—Tachycardia—Dexamethasone—allergic rhinitis	8.65e-05	0.000382	CcSEcCtD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	8.62e-05	0.000987	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—IL5—allergic rhinitis	8.62e-05	0.000987	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—TAC1—allergic rhinitis	8.62e-05	0.000986	CbGpPWpGaD
Carvedilol—Dyspepsia—Triamcinolone—allergic rhinitis	8.6e-05	0.000379	CcSEcCtD
Carvedilol—Dyspepsia—Methylprednisolone—allergic rhinitis	8.58e-05	0.000379	CcSEcCtD
Carvedilol—Hyperhidrosis—Betamethasone—allergic rhinitis	8.57e-05	0.000378	CcSEcCtD
Carvedilol—Hyperhidrosis—Dexamethasone—allergic rhinitis	8.57e-05	0.000378	CcSEcCtD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	8.56e-05	0.00098	CbGpPWpGaD
Carvedilol—Feeling abnormal—Hydrocortisone—allergic rhinitis	8.55e-05	0.000377	CcSEcCtD
Carvedilol—VCAM1—Immune System—ICAM1—allergic rhinitis	8.5e-05	0.000973	CbGpPWpGaD
Carvedilol—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	8.48e-05	0.000374	CcSEcCtD
Carvedilol—Anorexia—Betamethasone—allergic rhinitis	8.45e-05	0.000373	CcSEcCtD
Carvedilol—Anorexia—Dexamethasone—allergic rhinitis	8.45e-05	0.000373	CcSEcCtD
Carvedilol—Urticaria—Prednisolone—allergic rhinitis	8.44e-05	0.000372	CcSEcCtD
Carvedilol—Fatigue—Triamcinolone—allergic rhinitis	8.42e-05	0.000372	CcSEcCtD
Carvedilol—ADRA2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	8.41e-05	0.000963	CbGpPWpGaD
Carvedilol—Fatigue—Methylprednisolone—allergic rhinitis	8.4e-05	0.000371	CcSEcCtD
Carvedilol—Pain—Triamcinolone—allergic rhinitis	8.35e-05	0.000369	CcSEcCtD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.34e-05	0.000955	CbGpPWpGaD
Carvedilol—Hypotension—Dexamethasone—allergic rhinitis	8.28e-05	0.000366	CcSEcCtD
Carvedilol—Hypotension—Betamethasone—allergic rhinitis	8.28e-05	0.000366	CcSEcCtD
Carvedilol—Urticaria—Hydrocortisone—allergic rhinitis	8.24e-05	0.000364	CcSEcCtD
Carvedilol—Body temperature increased—Hydrocortisone—allergic rhinitis	8.2e-05	0.000362	CcSEcCtD
Carvedilol—Abdominal pain—Hydrocortisone—allergic rhinitis	8.2e-05	0.000362	CcSEcCtD
Carvedilol—ADRA2A—GPCR ligand binding—CCL11—allergic rhinitis	8.13e-05	0.00093	CbGpPWpGaD
Carvedilol—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	8.08e-05	0.000356	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	8.08e-05	0.000356	CcSEcCtD
Carvedilol—ADRB1—GPCR downstream signaling—PTGDR2—allergic rhinitis	8.06e-05	0.000922	CbGpPWpGaD
Carvedilol—Feeling abnormal—Triamcinolone—allergic rhinitis	8.05e-05	0.000355	CcSEcCtD
Carvedilol—Feeling abnormal—Methylprednisolone—allergic rhinitis	8.03e-05	0.000354	CcSEcCtD
Carvedilol—ADRA1D—Signaling by GPCR—PTGDR2—allergic rhinitis	8.03e-05	0.000919	CbGpPWpGaD
Carvedilol—Insomnia—Dexamethasone—allergic rhinitis	8.02e-05	0.000354	CcSEcCtD
Carvedilol—Insomnia—Betamethasone—allergic rhinitis	8.02e-05	0.000354	CcSEcCtD
Carvedilol—ADRA2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.99e-05	0.000914	CbGpPWpGaD
Carvedilol—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	7.97e-05	0.000352	CcSEcCtD
Carvedilol—Paraesthesia—Betamethasone—allergic rhinitis	7.96e-05	0.000351	CcSEcCtD
Carvedilol—Paraesthesia—Dexamethasone—allergic rhinitis	7.96e-05	0.000351	CcSEcCtD
Carvedilol—ADRB2—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.88e-05	0.000902	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—SMAD3—allergic rhinitis	7.88e-05	0.000901	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—TAC1—allergic rhinitis	7.85e-05	0.000899	CbGpPWpGaD
Carvedilol—Hypersensitivity—Prednisolone—allergic rhinitis	7.83e-05	0.000345	CcSEcCtD
Carvedilol—Dyspepsia—Betamethasone—allergic rhinitis	7.8e-05	0.000344	CcSEcCtD
Carvedilol—Dyspepsia—Dexamethasone—allergic rhinitis	7.8e-05	0.000344	CcSEcCtD
Carvedilol—ADRA2B—GPCR ligand binding—TAC1—allergic rhinitis	7.78e-05	0.00089	CbGpPWpGaD
Carvedilol—Urticaria—Triamcinolone—allergic rhinitis	7.76e-05	0.000342	CcSEcCtD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.75e-05	0.000887	CbGpPWpGaD
Carvedilol—Urticaria—Methylprednisolone—allergic rhinitis	7.74e-05	0.000342	CcSEcCtD
Carvedilol—Body temperature increased—Triamcinolone—allergic rhinitis	7.72e-05	0.000341	CcSEcCtD
Carvedilol—Abdominal pain—Methylprednisolone—allergic rhinitis	7.71e-05	0.00034	CcSEcCtD
Carvedilol—Decreased appetite—Betamethasone—allergic rhinitis	7.71e-05	0.00034	CcSEcCtD
Carvedilol—Decreased appetite—Dexamethasone—allergic rhinitis	7.71e-05	0.00034	CcSEcCtD
Carvedilol—ADRB2—GPCR ligand binding—TAC1—allergic rhinitis	7.68e-05	0.000879	CbGpPWpGaD
Carvedilol—Gastrointestinal disorder—Betamethasone—allergic rhinitis	7.65e-05	0.000338	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	7.65e-05	0.000338	CcSEcCtD
Carvedilol—Hypersensitivity—Hydrocortisone—allergic rhinitis	7.64e-05	0.000337	CcSEcCtD
Carvedilol—Fatigue—Betamethasone—allergic rhinitis	7.64e-05	0.000337	CcSEcCtD
Carvedilol—Fatigue—Dexamethasone—allergic rhinitis	7.64e-05	0.000337	CcSEcCtD
Carvedilol—Pain—Betamethasone—allergic rhinitis	7.58e-05	0.000334	CcSEcCtD
Carvedilol—Pain—Dexamethasone—allergic rhinitis	7.58e-05	0.000334	CcSEcCtD
Carvedilol—ADRB3—GPCR downstream signaling—TAC1—allergic rhinitis	7.48e-05	0.000856	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.46e-05	0.000854	CbGpPWpGaD
Carvedilol—Asthenia—Hydrocortisone—allergic rhinitis	7.44e-05	0.000328	CcSEcCtD
Carvedilol—ADRA1B—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.34e-05	0.00084	CbGpPWpGaD
Carvedilol—Pruritus—Hydrocortisone—allergic rhinitis	7.34e-05	0.000324	CcSEcCtD
Carvedilol—ADRB1—Signaling by GPCR—PTGDR2—allergic rhinitis	7.32e-05	0.000838	CbGpPWpGaD
Carvedilol—Feeling abnormal—Betamethasone—allergic rhinitis	7.31e-05	0.000322	CcSEcCtD
Carvedilol—Feeling abnormal—Dexamethasone—allergic rhinitis	7.31e-05	0.000322	CcSEcCtD
Carvedilol—ADRB3—Signaling Pathways—PTGDR2—allergic rhinitis	7.28e-05	0.000834	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PTGDR2—allergic rhinitis	7.27e-05	0.000832	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—TAC1—allergic rhinitis	7.27e-05	0.000832	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—PTGDR2—allergic rhinitis	7.25e-05	0.00083	CbGpPWpGaD
Carvedilol—Gastrointestinal pain—Dexamethasone—allergic rhinitis	7.25e-05	0.00032	CcSEcCtD
Carvedilol—Gastrointestinal pain—Betamethasone—allergic rhinitis	7.25e-05	0.00032	CcSEcCtD
Carvedilol—Hypersensitivity—Triamcinolone—allergic rhinitis	7.2e-05	0.000318	CcSEcCtD
Carvedilol—Hypersensitivity—Methylprednisolone—allergic rhinitis	7.18e-05	0.000317	CcSEcCtD
Carvedilol—ADRB2—Signaling by GPCR—PTGDR2—allergic rhinitis	7.16e-05	0.000819	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—TAC1—allergic rhinitis	7.15e-05	0.000819	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.13e-05	0.000816	CbGpPWpGaD
Carvedilol—Diarrhoea—Hydrocortisone—allergic rhinitis	7.1e-05	0.000313	CcSEcCtD
Carvedilol—Urticaria—Dexamethasone—allergic rhinitis	7.04e-05	0.000311	CcSEcCtD
Carvedilol—Urticaria—Betamethasone—allergic rhinitis	7.04e-05	0.000311	CcSEcCtD
Carvedilol—Dizziness—Prednisolone—allergic rhinitis	7.03e-05	0.00031	CcSEcCtD
Carvedilol—Asthenia—Triamcinolone—allergic rhinitis	7.01e-05	0.000309	CcSEcCtD
Carvedilol—Body temperature increased—Dexamethasone—allergic rhinitis	7.01e-05	0.000309	CcSEcCtD
Carvedilol—Body temperature increased—Betamethasone—allergic rhinitis	7.01e-05	0.000309	CcSEcCtD
Carvedilol—Abdominal pain—Dexamethasone—allergic rhinitis	7.01e-05	0.000309	CcSEcCtD
Carvedilol—Abdominal pain—Betamethasone—allergic rhinitis	7.01e-05	0.000309	CcSEcCtD
Carvedilol—Asthenia—Methylprednisolone—allergic rhinitis	6.99e-05	0.000309	CcSEcCtD
Carvedilol—ADRB3—GPCR downstream signaling—IL5—allergic rhinitis	6.95e-05	0.000795	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.94e-05	0.000794	CbGpPWpGaD
Carvedilol—Pruritus—Triamcinolone—allergic rhinitis	6.91e-05	0.000305	CcSEcCtD
Carvedilol—Pruritus—Methylprednisolone—allergic rhinitis	6.9e-05	0.000304	CcSEcCtD
Carvedilol—Dizziness—Hydrocortisone—allergic rhinitis	6.86e-05	0.000303	CcSEcCtD
Carvedilol—ADRB3—Signaling by GPCR—TAC1—allergic rhinitis	6.79e-05	0.000777	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—PTGDR2—allergic rhinitis	6.77e-05	0.000775	CbGpPWpGaD
Carvedilol—Rash—Prednisolone—allergic rhinitis	6.7e-05	0.000296	CcSEcCtD
Carvedilol—Dermatitis—Prednisolone—allergic rhinitis	6.69e-05	0.000295	CcSEcCtD
Carvedilol—Diarrhoea—Methylprednisolone—allergic rhinitis	6.67e-05	0.000294	CcSEcCtD
Carvedilol—ADRA1B—Signaling by GPCR—PTGDR2—allergic rhinitis	6.67e-05	0.000763	CbGpPWpGaD
Carvedilol—Headache—Prednisolone—allergic rhinitis	6.66e-05	0.000294	CcSEcCtD
Carvedilol—VEGFA—Cellular responses to stress—NFKB1—allergic rhinitis	6.61e-05	0.000756	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	6.6e-05	0.000755	CbGpPWpGaD
Carvedilol—Vomiting—Hydrocortisone—allergic rhinitis	6.6e-05	0.000291	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Hydrocortisone—allergic rhinitis	6.59e-05	0.0109	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Hydrocortisone—allergic rhinitis	6.59e-05	0.0109	CbGdCrCtD
Carvedilol—Rash—Hydrocortisone—allergic rhinitis	6.54e-05	0.000289	CcSEcCtD
Carvedilol—Dermatitis—Hydrocortisone—allergic rhinitis	6.54e-05	0.000288	CcSEcCtD
Carvedilol—ADRA1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.52e-05	0.000746	CbGpPWpGaD
Carvedilol—Headache—Hydrocortisone—allergic rhinitis	6.5e-05	0.000287	CcSEcCtD
Carvedilol—ADRA2B—Hemostasis—IL5—allergic rhinitis	6.47e-05	0.00074	CbGpPWpGaD
Carvedilol—Dizziness—Triamcinolone—allergic rhinitis	6.46e-05	0.000285	CcSEcCtD
Carvedilol—Dizziness—Methylprednisolone—allergic rhinitis	6.45e-05	0.000284	CcSEcCtD
Carvedilol—Asthenia—Dexamethasone—allergic rhinitis	6.36e-05	0.000281	CcSEcCtD
Carvedilol—Asthenia—Betamethasone—allergic rhinitis	6.36e-05	0.000281	CcSEcCtD
Carvedilol—ADRA1A—GPCR ligand binding—TAC1—allergic rhinitis	6.35e-05	0.000727	CbGpPWpGaD
Carvedilol—VEGFA—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	6.35e-05	0.000726	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.32e-05	0.000724	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL5—allergic rhinitis	6.31e-05	0.000722	CbGpPWpGaD
Carvedilol—Nausea—Prednisolone—allergic rhinitis	6.31e-05	0.000278	CcSEcCtD
Carvedilol—ADRA1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.3e-05	0.000721	CbGpPWpGaD
Carvedilol—Pruritus—Dexamethasone—allergic rhinitis	6.27e-05	0.000277	CcSEcCtD
Carvedilol—Pruritus—Betamethasone—allergic rhinitis	6.27e-05	0.000277	CcSEcCtD
Carvedilol—ADRA2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.27e-05	0.000717	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD4—allergic rhinitis	6.25e-05	0.000715	CbGpPWpGaD
Carvedilol—GJA1—Betamethasone—Methylprednisolone—allergic rhinitis	6.22e-05	0.0103	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Methylprednisolone—allergic rhinitis	6.22e-05	0.0103	CbGdCrCtD
Carvedilol—Vomiting—Triamcinolone—allergic rhinitis	6.21e-05	0.000274	CcSEcCtD
Carvedilol—Vomiting—Methylprednisolone—allergic rhinitis	6.2e-05	0.000273	CcSEcCtD
Carvedilol—ADRB2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.19e-05	0.000708	CbGpPWpGaD
Carvedilol—Nausea—Hydrocortisone—allergic rhinitis	6.16e-05	0.000272	CcSEcCtD
Carvedilol—Rash—Triamcinolone—allergic rhinitis	6.16e-05	0.000272	CcSEcCtD
Carvedilol—Dermatitis—Triamcinolone—allergic rhinitis	6.15e-05	0.000272	CcSEcCtD
Carvedilol—Rash—Methylprednisolone—allergic rhinitis	6.15e-05	0.000271	CcSEcCtD
Carvedilol—Dermatitis—Methylprednisolone—allergic rhinitis	6.14e-05	0.000271	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Betamethasone—allergic rhinitis	6.12e-05	0.0101	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Dexamethasone—allergic rhinitis	6.12e-05	0.0101	CbGdCrCtD
Carvedilol—Headache—Triamcinolone—allergic rhinitis	6.12e-05	0.00027	CcSEcCtD
Carvedilol—Headache—Methylprednisolone—allergic rhinitis	6.11e-05	0.000269	CcSEcCtD
Carvedilol—ADRA1D—Signaling by GPCR—CCL11—allergic rhinitis	6.09e-05	0.000697	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—SMAD3—allergic rhinitis	6.07e-05	0.000694	CbGpPWpGaD
Carvedilol—Diarrhoea—Betamethasone—allergic rhinitis	6.07e-05	0.000268	CcSEcCtD
Carvedilol—Diarrhoea—Dexamethasone—allergic rhinitis	6.07e-05	0.000268	CcSEcCtD
Carvedilol—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.06e-05	0.000693	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—IL5—allergic rhinitis	6.04e-05	0.000691	CbGpPWpGaD
Carvedilol—GJA1—Betamethasone—Triamcinolone—allergic rhinitis	5.98e-05	0.00986	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Triamcinolone—allergic rhinitis	5.98e-05	0.00986	CbGdCrCtD
Carvedilol—ADRA1A—Signaling by GPCR—PTGDR2—allergic rhinitis	5.92e-05	0.000678	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	5.9e-05	0.000676	CbGpPWpGaD
Carvedilol—Dizziness—Betamethasone—allergic rhinitis	5.86e-05	0.000259	CcSEcCtD
Carvedilol—Dizziness—Dexamethasone—allergic rhinitis	5.86e-05	0.000259	CcSEcCtD
Carvedilol—ADRA2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.85e-05	0.00067	CbGpPWpGaD
Carvedilol—VEGFA—Dexamethasone—Hydrocortisone—allergic rhinitis	5.81e-05	0.00957	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Hydrocortisone—allergic rhinitis	5.81e-05	0.00957	CbGdCrCtD
Carvedilol—Nausea—Triamcinolone—allergic rhinitis	5.8e-05	0.000256	CcSEcCtD
Carvedilol—Nausea—Methylprednisolone—allergic rhinitis	5.79e-05	0.000255	CcSEcCtD
Carvedilol—ADRA1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.76e-05	0.000659	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.74e-05	0.000657	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CYSLTR1—allergic rhinitis	5.72e-05	0.000654	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CYSLTR1—allergic rhinitis	5.7e-05	0.000653	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.69e-05	0.000651	CbGpPWpGaD
Carvedilol—Vomiting—Dexamethasone—allergic rhinitis	5.64e-05	0.000249	CcSEcCtD
Carvedilol—Vomiting—Betamethasone—allergic rhinitis	5.64e-05	0.000249	CcSEcCtD
Carvedilol—ADRB2—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.62e-05	0.000643	CbGpPWpGaD
Carvedilol—Rash—Dexamethasone—allergic rhinitis	5.59e-05	0.000247	CcSEcCtD
Carvedilol—Rash—Betamethasone—allergic rhinitis	5.59e-05	0.000247	CcSEcCtD
Carvedilol—Dermatitis—Betamethasone—allergic rhinitis	5.58e-05	0.000246	CcSEcCtD
Carvedilol—Dermatitis—Dexamethasone—allergic rhinitis	5.58e-05	0.000246	CcSEcCtD
Carvedilol—Headache—Betamethasone—allergic rhinitis	5.55e-05	0.000245	CcSEcCtD
Carvedilol—Headache—Dexamethasone—allergic rhinitis	5.55e-05	0.000245	CcSEcCtD
Carvedilol—ADRB1—Signaling by GPCR—CCL11—allergic rhinitis	5.55e-05	0.000635	CbGpPWpGaD
Carvedilol—GJA1—Dexamethasone—Prednisolone—allergic rhinitis	5.54e-05	0.00913	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Prednisolone—allergic rhinitis	5.54e-05	0.00913	CbGdCrCtD
Carvedilol—ADRB3—Signaling Pathways—CCL11—allergic rhinitis	5.52e-05	0.000632	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CCL11—allergic rhinitis	5.51e-05	0.00063	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	5.5e-05	0.00063	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	5.5e-05	0.000629	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CCL11—allergic rhinitis	5.5e-05	0.000629	CbGpPWpGaD
Carvedilol—VEGFA—Betamethasone—Methylprednisolone—allergic rhinitis	5.48e-05	0.00903	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Methylprednisolone—allergic rhinitis	5.48e-05	0.00903	CbGdCrCtD
Carvedilol—ADRB2—Signaling by GPCR—CCL11—allergic rhinitis	5.43e-05	0.000621	CbGpPWpGaD
Carvedilol—VEGFA—Dexamethasone—Betamethasone—allergic rhinitis	5.4e-05	0.00889	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Dexamethasone—allergic rhinitis	5.4e-05	0.00889	CbGdCrCtD
Carvedilol—VCAM1—Immune System—NFKB1—allergic rhinitis	5.38e-05	0.000616	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.32e-05	0.000608	CbGpPWpGaD
Carvedilol—VEGFA—Dexamethasone—Triamcinolone—allergic rhinitis	5.27e-05	0.00869	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Triamcinolone—allergic rhinitis	5.27e-05	0.00869	CbGdCrCtD
Carvedilol—Nausea—Betamethasone—allergic rhinitis	5.27e-05	0.000232	CcSEcCtD
Carvedilol—Nausea—Dexamethasone—allergic rhinitis	5.27e-05	0.000232	CcSEcCtD
Carvedilol—ADRA1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.23e-05	0.000599	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CCL11—allergic rhinitis	5.13e-05	0.000587	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.12e-05	0.000586	CbGpPWpGaD
Carvedilol—HIF1A—Disease—CD4—allergic rhinitis	5.11e-05	0.000585	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CCL11—allergic rhinitis	5.05e-05	0.000578	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—IL5—allergic rhinitis	4.91e-05	0.000562	CbGpPWpGaD
Carvedilol—VEGFA—Betamethasone—Prednisolone—allergic rhinitis	4.88e-05	0.00805	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Prednisolone—allergic rhinitis	4.88e-05	0.00805	CbGdCrCtD
Carvedilol—ADRA1D—GPCR downstream signaling—TAC1—allergic rhinitis	4.87e-05	0.000557	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.75e-05	0.000544	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PTGDR2—allergic rhinitis	4.75e-05	0.000543	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.65e-05	0.000532	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—IL5—allergic rhinitis	4.53e-05	0.000518	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCL11—allergic rhinitis	4.49e-05	0.000514	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	4.47e-05	0.000511	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—TAC1—allergic rhinitis	4.44e-05	0.000508	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—TAC1—allergic rhinitis	4.42e-05	0.000506	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—TAC1—allergic rhinitis	4.4e-05	0.000503	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—TAC1—allergic rhinitis	4.34e-05	0.000497	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PTGDR2—allergic rhinitis	4.32e-05	0.000495	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.32e-05	0.000494	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PTGDR2—allergic rhinitis	4.28e-05	0.00049	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PTGDR2—allergic rhinitis	4.23e-05	0.000484	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	4.17e-05	0.000477	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—IL5—allergic rhinitis	4.13e-05	0.000472	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL5—allergic rhinitis	4.11e-05	0.000471	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—TAC1—allergic rhinitis	4.11e-05	0.00047	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—IL5—allergic rhinitis	4.09e-05	0.000468	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—TAC1—allergic rhinitis	4.04e-05	0.000463	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—IL5—allergic rhinitis	4.04e-05	0.000462	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—TAC1—allergic rhinitis	4.03e-05	0.000461	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TAC1—allergic rhinitis	4.01e-05	0.000459	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—NFKB1—allergic rhinitis	4e-05	0.000458	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TAC1—allergic rhinitis	4e-05	0.000458	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PTGDR2—allergic rhinitis	4e-05	0.000458	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—TAC1—allergic rhinitis	3.99e-05	0.000457	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—TAC1—allergic rhinitis	3.94e-05	0.000451	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PTGDR2—allergic rhinitis	3.94e-05	0.000451	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—IL5—allergic rhinitis	3.82e-05	0.000437	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—IL5—allergic rhinitis	3.76e-05	0.00043	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL5—allergic rhinitis	3.75e-05	0.000429	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.74e-05	0.000428	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—TAC1—allergic rhinitis	3.73e-05	0.000427	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL5—allergic rhinitis	3.73e-05	0.000427	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CYSLTR1—allergic rhinitis	3.72e-05	0.000426	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL5—allergic rhinitis	3.72e-05	0.000426	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL5—allergic rhinitis	3.71e-05	0.000425	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—TAC1—allergic rhinitis	3.67e-05	0.00042	CbGpPWpGaD
Carvedilol—HIF1A—Disease—TGFB1—allergic rhinitis	3.67e-05	0.00042	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL5—allergic rhinitis	3.67e-05	0.000419	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCL11—allergic rhinitis	3.6e-05	0.000412	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—TAC1—allergic rhinitis	3.59e-05	0.000411	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PTGDR2—allergic rhinitis	3.5e-05	0.0004	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.49e-05	0.0004	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL5—allergic rhinitis	3.47e-05	0.000397	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL5—allergic rhinitis	3.41e-05	0.000391	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.39e-05	0.000388	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CYSLTR1—allergic rhinitis	3.36e-05	0.000385	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—IL5—allergic rhinitis	3.34e-05	0.000382	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	3.34e-05	0.000382	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—TGFB1—allergic rhinitis	3.33e-05	0.000382	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CYSLTR1—allergic rhinitis	3.32e-05	0.00038	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCL11—allergic rhinitis	3.28e-05	0.000375	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—TGFB1—allergic rhinitis	3.27e-05	0.000374	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—TAC1—allergic rhinitis	3.26e-05	0.000373	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	3.25e-05	0.000372	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCL11—allergic rhinitis	3.25e-05	0.000372	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCL11—allergic rhinitis	3.21e-05	0.000367	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CYSLTR1—allergic rhinitis	3.14e-05	0.000359	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	3.1e-05	0.000355	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CYSLTR1—allergic rhinitis	3.09e-05	0.000354	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—NFKB1—allergic rhinitis	3.08e-05	0.000353	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCL11—allergic rhinitis	3.03e-05	0.000347	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL5—allergic rhinitis	3.03e-05	0.000347	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	3.03e-05	0.000347	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCL11—allergic rhinitis	2.98e-05	0.000342	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.84e-05	0.000325	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	2.82e-05	0.000322	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.75e-05	0.000314	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL11—allergic rhinitis	2.65e-05	0.000303	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.65e-05	0.000303	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SMAD3—allergic rhinitis	2.62e-05	0.0003	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SMAD3—allergic rhinitis	2.62e-05	0.0003	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TAC1—allergic rhinitis	2.61e-05	0.000299	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—TGFB1—allergic rhinitis	2.57e-05	0.000294	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.55e-05	0.000292	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	2.46e-05	0.000282	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL5—allergic rhinitis	2.43e-05	0.000278	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TAC1—allergic rhinitis	2.38e-05	0.000272	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TAC1—allergic rhinitis	2.36e-05	0.00027	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TAC1—allergic rhinitis	2.33e-05	0.000266	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL5—allergic rhinitis	2.21e-05	0.000253	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.21e-05	0.000252	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TAC1—allergic rhinitis	2.2e-05	0.000252	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL5—allergic rhinitis	2.19e-05	0.000251	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TAC1—allergic rhinitis	2.17e-05	0.000248	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL5—allergic rhinitis	2.17e-05	0.000248	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL5—allergic rhinitis	2.05e-05	0.000234	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL5—allergic rhinitis	2.02e-05	0.000231	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TGFB1—allergic rhinitis	1.93e-05	0.000221	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TAC1—allergic rhinitis	1.93e-05	0.00022	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TGFB1—allergic rhinitis	1.8e-05	0.000206	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL5—allergic rhinitis	1.79e-05	0.000205	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	1.79e-05	0.000205	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SMAD3—allergic rhinitis	1.71e-05	0.000196	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	1.66e-05	0.00019	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SMAD3—allergic rhinitis	1.56e-05	0.000178	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SMAD3—allergic rhinitis	1.54e-05	0.000177	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SMAD3—allergic rhinitis	1.52e-05	0.000174	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	1.46e-05	0.000167	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SMAD3—allergic rhinitis	1.44e-05	0.000165	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SMAD3—allergic rhinitis	1.42e-05	0.000162	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NFKB1—allergic rhinitis	1.33e-05	0.000153	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NFKB1—allergic rhinitis	1.33e-05	0.000152	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SMAD3—allergic rhinitis	1.26e-05	0.000144	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	1.17e-05	0.000134	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—allergic rhinitis	1.11e-05	0.000127	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—allergic rhinitis	1.11e-05	0.000127	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NFKB1—allergic rhinitis	8.69e-06	9.94e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NFKB1—allergic rhinitis	7.92e-06	9.06e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NFKB1—allergic rhinitis	7.85e-06	8.98e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NFKB1—allergic rhinitis	7.75e-06	8.86e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NFKB1—allergic rhinitis	7.33e-06	8.39e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—allergic rhinitis	7.24e-06	8.28e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NFKB1—allergic rhinitis	7.21e-06	8.25e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—allergic rhinitis	6.6e-06	7.55e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—allergic rhinitis	6.54e-06	7.48e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—allergic rhinitis	6.45e-06	7.38e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NFKB1—allergic rhinitis	6.41e-06	7.33e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—allergic rhinitis	6.11e-06	6.99e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—allergic rhinitis	6.01e-06	6.88e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	5.95e-06	6.81e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—allergic rhinitis	5.34e-06	6.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	4.96e-06	5.67e-05	CbGpPWpGaD
